Indefinite Delivery Contract SPM20005D3012

Award Date 1/25/05
Last Date to Order 12/31/18
Funding Federal Agency
Not listed
Contracting Federal Agency
Medical Supply Chain
Ultimate Awardee
Cardinal Health, Inc.
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large healthcare services and products company, to provide a wide range of pharmaceutical and medical supplies to the U.S. federal government. The single-award, $4.9 million IDC has a performance period from January 25, 2005, through December 31, 2018, with no set-asides used. The contract primarily supports the DLA's Pharmaceutical Prime Vendor program, which supplies medical...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $0, is for the provision of pharmaceutical and medical products to support the DLA's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical items to military treatment facilities and deployed troops worldwide. The contract...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company. The contract, valued at $0.00, is for the provision of pharmaceutical products and medical supplies to support military treatment facilities and deployed troops worldwide under the DLA Pharmaceutical Prime Vendor program. The contract has a base period from January 25, 2005 to March 31, 2015 and does not utilize any...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company, to serve as the prime vendor for the DLA's Pharmaceutical Prime Vendor program. The $150,000,000 single-award contract has a period of performance from July 1, 2010 to June 30, 2015, with no set-aside designation. Under this IDC, Cardinal Health has received numerous firm fixed-price delivery orders to supply a wide range...
The federal contract IDV awarded to Cardinal Health, Inc. by the Department of Defense's Defense Logistics Agency (DLA) is for the provision of pharmaceutical and medical supply distribution services under the Pharmaceutical Prime Vendor program. The single-award indefinite delivery contract, valued at $0.00, has a base period through March 31, 2015. The contract enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including antibiotics, pain...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company, to provide a wide range of pharmaceutical and medical supplies to support military treatment facilities and deployed troops under the DLA Pharmaceutical Prime Vendor program. The single-award contract, valued at up to $4.9 million, has a period of performance from January 25, 2005 to December 31, 2018 and does not include...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit corporation, to provide pharmaceutical distribution services under the DLA Pharmaceutical Prime Vendor program. The contract has a ceiling value of $0.00 and a period of performance from January 25, 2005 to March 31, 2015. The contract allows the Department of Defense (DoD), including TRICARE West, to issue firm fixed-price delivery orders for a wide range of...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company, to provide a wide range of pharmaceutical and medical products to the Department of Defense (DoD) and other federal agencies. The contract has a base period through March 31, 2015, and does not utilize any set-asides. The contract facilitates the supply of various medications, vaccines, and other medical consumables to...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, to provide a wide range of pharmaceutical and medical supplies to the U.S. federal government. The single-award IDC has a ceiling value of $9,999,999,999.00 and a period of performance through May 31, 2015. Cardinal Health delivers products such as antibiotics, pain medications, vaccines, radiopharmaceuticals, and specialty drugs...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major healthcare services and products company, to provide pharmaceutical and medical supply distribution services to the U.S. federal government. The single-award contract, valued at an unspecified ceiling, has a period of performance from January 25, 2005, through March 31, 2015. The contract aims to supply a comprehensive range of medical products, including prescription...
  • SPM20005D3012
    Indefinite Delivery Contract
  • 8.8K
    Federal Contract Awards

The key products and services being delivered under this federal contract IDV award are pharmaceutical and medical supply distribution services for the Defense Logistics Agency (DLA). Cardinal Health, Inc., a large, for-profit healthcare services company, was awarded this single-award Indefinite Delivery Contract (IDC) valued at $4.9 million with the DLA. The period of performance runs from January 25, 2005 to December 31, 2018.

Through this IDC, Cardinal Health has received numerous firm fixed-price delivery orders to supply a variety of pharmaceutical products including antibiotics, pain medications, vaccines, and specialty drugs to military treatment facilities and deployed troops worldwide under the DLA's Pharmaceutical Prime Vendor program. The delivery orders, which have no set-aside designations, are primarily for the TRICARE West region, with a total ceiling value across the task orders of over $400,000. The contracted services support the DLA's mission to provide comprehensive medical supplies and solutions to the U.S. Department of Defense.

Generated 11/23/24, 9:10 AM